Hallux Valgus Treatment Developed for Children With Cerebral Palsy

Launched by ISTANBUL AREL UNIVERSITY · Oct 6, 2023

Keywords

ClinConnect Summary

This clinical trial is examining a new way to treat hallux valgus, a common foot deformity in children with diplegic cerebral palsy. Hallux valgus can make it difficult for these children to walk and participate in daily activities, often leading to the need for surgery. The researchers want to explore how specific exercises and movements guided by physiotherapists can help improve this condition in its early stages, hopefully reducing the need for surgery in the future.

To participate in this study, children aged 9 to 16 who have been diagnosed with spastic diplegic cerebral palsy and who can walk independently may be eligible. They should have a mild form of hallux valgus and not require any assistive devices to walk. Throughout the trial, participants will engage in an exercise program tailored to help correct their foot deformity. The study is not yet recruiting participants, but it aims to provide valuable insights into non-surgical treatment options for children facing this challenge.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being diagnosed with cerebral palsy,
• • Being a spastic diplegic type of cerebral palsy,
• • Age range 9-16,
• • Communication Function Classification System Level 1 and 2,
• • Children with ambulatory level GMFCS 1-2,
• • Using AFO and GRAFO,
• • Children who do not use any assistive devices,
• • Children with Manchester scale Stage 1 and 2 hallux valgus will be included in the study.
• Exclusion Criteria:
• • Those who cannot walk independently,
• • GMSCS 3 and above,
• • Does not use AFO and GRAFO,
• • Children using assistive devices,
• • Communication Function Classification System Level 3 and above,
• • Manchester scale stage 3 hallux valgus,
• • Children with spasticity values above 1+ according to the Modified Ashworth Scale will be excluded from the study.